PD-L1 Antibodies
(CD274 (PD-L1))
Choose one of 278 PD-L1 antibodies from our product listing based on 15 publications and 135 validation images.
Explore reliable PD-L1 antibodies from a broad selection of renowned manufacturers. Our portfolio enables accurate PD-L1 detection across multiple species, including Human, Mouse, Rat, Non-Human Primate, Pig, Cow, Monkey, Dog, Horse, and supports diverse research applications such as WB, FACS, ELISA, IHC, IF (cc).
Quickly find the right antibody using our search, filter, and comparison tools. Each product page provides detailed validation data, literature references, and customer feedback. Unlike comparison-only resources, you can conveniently purchase antibodies directly through our site. Choose from polyclonal, monoclonal, or recombinant PD-L1 antibodies derived from various hosts such as Rabbit, Mouse, Rat. Browse our products below and order directly to support your research with confidence.
Alternative names for PD-L1 are CD274, Cd274, PDCD1LG2.
Recommended next Filters:
Would you like to try our new AI Search?
278 results
PD-L1
Reactivity: Human
FACS, ELISA, Func, BLI, SPR
Host: Human
Monoclonal
MDX-1105
unconjugated
Recombinant Antibody
PD-L1
Reactivity: Human
WB, FACS, IHC, ICC
Host: HEK-293F Cells
Monoclonal
FITC
PD-L1
Reactivity: Human
FACS, ELISA, BR
Host: Mouse
Monoclonal
2-7A4
unconjugated
Recombinant Antibody
PD-L1
Reactivity: Human
ELISA, Coat
Host: Mouse
Monoclonal
PDL1-2741
unconjugated
PD-L1
Reactivity: Human
WB, FACS, ELISA, IF, Coat, IHC (f)
Host: Mouse
Monoclonal
PDL1-2746
unconjugated
PD-L1
Reactivity: Human
FACS, IHC, ELISA, IF, Coat
Host: Mouse
Monoclonal
PDL1-2743
unconjugated
PD-L1
Reactivity: Human
WB, ELISA, Coat
Host: Mouse
Monoclonal
PDL1-2744
unconjugated
PD-L1
Reactivity: Human
WB, FACS, IF, IHC (f)
Host: Rabbit
Monoclonal
unconjugated
Recombinant Antibody
PD-L1
Reactivity: Human
WB, IHC (f)
Host: Mouse
Monoclonal
unconjugated
Recombinant Antibody
PD-L1
Reactivity: Mouse
FACS
Host: Rat
Monoclonal
YDC 127-1-1
unconjugated
Recombinant Antibody
PD-L1
Reactivity: Human
FACS, BR
Host: Human
Monoclonal
332M7
unconjugated
Recombinant Antibody
PD-L1
Reactivity: Human
FACS, BR
Host: Rabbit
Chimeric
332M7
unconjugated
Recombinant Antibody
PD-L1
Reactivity: Human
IHC, ELISA
Host: Rabbit
Chimeric
B7HC0013
unconjugated
Recombinant Antibody
PD-L1
Reactivity: Human
IHC, ELISA
Host: Mouse
Monoclonal
B7HC0013
unconjugated
Recombinant Antibody
PD-L1
Reactivity: Human
FACS, IHC
Host: Human
Chimeric
XGMHc25-1
unconjugated
Recombinant Antibody
PD-L1
Reactivity: Mouse
FACS, IHC, ELISA, BP
Host: Rat
Monoclonal
10F-9G2
unconjugated
Recombinant Antibody
PD-L1
Reactivity: Mouse
FACS, IHC, ELISA, BP
Host: Rabbit
Chimeric
10F-9G2
unconjugated
Recombinant Antibody
Latest Publications for our PD-L1 Antibodies
: "Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin." in: PLoS ONE, Vol. 16, Issue 1, pp. e0245581, (2021) (PubMed).: "Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma." in: Frontiers in oncology, Vol. 11, pp. 757919, (2021) (PubMed).
: "Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder." in: Journal of clinical medicine, Vol. 9, Issue 5, (2020) (PubMed).
: "NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer." in: Nature communications, Vol. 11, Issue 1, pp. 1669, (2020) (PubMed).
: "Tumor microenvironment predicts local tumor extensiveness in PD-L1 positive nasopharyngeal cancer." in: PLoS ONE, Vol. 15, Issue 3, pp. e0230449, (2020) (PubMed).
: "MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma." in: Aging, Vol. 12, Issue 2, pp. 1213-1236, (2020) (PubMed).
: "Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway. ..." in: Cancer immunology research, Vol. 7, Issue 5, pp. 841-852, (2019) (PubMed).
: "Autophagy inhibition enhances PD-L1 expression in gastric cancer." in: Journal of experimental & clinical cancer research : CR, Vol. 38, Issue 1, pp. 140, (2019) (PubMed).
: "Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy." in: PLoS ONE, Vol. 14, Issue 5, pp. e0215990, (2019) (PubMed).
: "Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy." in: Journal of controlled release : official journal of the Controlled Release Society, Vol. 308, pp. 29-43, (2019) (PubMed).
Aliases for PD-L1 Antibodies
CD274 molecule (CD274) AntibodiesCD274 antigen (Cd274) Antibodies
programmed cell death 1 ligand 2 (PDCD1LG2) Antibodies
CD274 molecule (Cd274) Antibodies
A530045L16Rik Antibodies
B7-H Antibodies
B7H1 Antibodies
B7h1 Antibodies
PD-L1 Antibodies
PDCD1L1 Antibodies
Pdcd1l1 Antibodies
PDCD1LG1 Antibodies
Pdcd1lg1 Antibodies
PDL1 Antibodies
Pdl1 Antibodies
RGD1566211 Antibodies
Did you look for something else?
- PD-1 Antibodies
- PCYT2 Antibodies
- PCYOX1L Antibodies
- PCYOX1 Antibodies
- PCTP Antibodies
- PCSK7 Antibodies
- PCSK6 Antibodies
- PCSK5 Antibodies
- PCSK4 Antibodies
- PCSK2 Antibodies
- PCSK1N Antibodies
- PCSK1 Antibodies
- PCP4 Antibodies
- Pcp2 Antibodies
- PCOTH Antibodies
- PCOLCE2 Antibodies
- PCOLCE Antibodies
- PCNXL2 Antibodies
- PCNT Antibodies
- PCNP Antibodies
- PDAP1 Antibodies
- PDCD11 Antibodies
- PDCD1LG2 Antibodies
- PDCD2 Antibodies
- PDCD2L Antibodies
- PDCD5 Antibodies
- PDCD6 Antibodies
- PDCD7 Antibodies
- PDCL2 Antibodies
- PDCL3 Antibodies
- PDE10A Antibodies
- PDE11A Antibodies
- PDE12 Antibodies
- PDE1A Antibodies
- PDE1B Antibodies
- PDE1C Antibodies
- PDE2A Antibodies
- PDE3A Antibodies
- PDE3B Antibodies
- PDE4A Antibodies
You are here:
